Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of… Nov 4, 2021
Small Pharma CEO On Innovative Passport Designation, Patents & More As Psychedelic Stock Surges Nov 1, 2021
European Patent Grant Strengthens Small Pharma’s Ketamine-Based Patent Portfolio for the Treatment of Depressive… Oct 25, 2021
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Oct 19, 2021
